Exercise program shows promise for cancer Patients' Well-Being
NCT ID NCT05816187
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 6-week supervised exercise program could improve quality of life and reduce fatigue in 78 breast and colon cancer patients. Participants were randomly assigned to either the exercise program or usual care, and were followed for one year. The main goal was to see if exercise helps patients feel better physically and emotionally.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- supervised therapeutic exercise
- What this could lead to
- If successful, this could show that a simple, supervised exercise program helps cancer patients feel better and have more energy during and after treatment.
- What could go wrong
- This is a small, completed study with only 78 participants. The results may not apply to all cancer patients, and the benefits of exercise might be modest or hard to separate from other factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
78 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18-70 years. * Oncological stage I, II or III. * Completed adjuvant treatment between 3 months to 2 years. ECOG 1-2. * Sign informed consent Exclusion Criteria: * Inability to read, understand and complete questionnaires, read and understand a brochure explanatory, understand and follow verbal orders (example; illiteracy, dementia or blindness). * Musculoskeletal disorders that prevent the exercise of the exercise bike, elliptical, march tape. * Important neurological disorders that involve impaired balance, coordination, ataxia. * Sporting activity at moderate intensity exceeding 150mnts / week. * Symptomatic anemia. * Fecal incontinence * Patient with a digestive ostomy. * Decompensated heart disease, * Uncontrolled hypertension * Heart failure. * Musculoskeletal pathology (except for upper limb pathology in cancer patients of mom) * Cardio-respiratory pathology that limits physical activity
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Infanta Leonor
Madrid, 28031, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a personalized menu keep cancer patients stronger through chemotherapy?
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?